Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill S Dolinsky

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Human Mutation|May 23, 2020
Mutation prevalence tables for hereditary cancer derived from multigene panel testingSteven N Hart, Eric C Polley, Amal Yussuf, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 26, 2014
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patientsHolly LaDuca, A J Stuenkel, Jill S Dolinsky, et al.
Journal of the National Cancer Institute|February 25, 2020
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing CohortChunling Hu, Eric C Polley, Siddhartha Yadav, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 20, 2019
Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohortHongyan Li, Holly LaDuca, Tina Pesaran, et al.
Cancer|April 14, 2019
Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinomaMary Linton B Peters, Lindsey Stobie, Beth Dudley, et al.
Medrxiv : the Preprint Server for Health Sciences|August 23, 2023
A genotype-first approach identifies high incidence of <i>NF1</i> pathogenic variants with distinct disease associationsAnton Safonov, Tomoki T Nomakuchi, Elizabeth Chao, et al.
JCO Precision Oncology|September 10, 2019
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility GenesChunling Hu, Holly LaDuca, Hermela Shimelis, et al.
Human Molecular Genetics|January 25, 2024
Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG/AMP guidelinesCristina Fortuno, Kyriaki Michailidou, Michael Parsons, et al.
JCO Precision Oncology|February 17, 2022
Unexpected <i>CDH1</i> Mutations Identified on Multigene Panels Pose Clinical Management ChallengesKatrina Lowstuter, Carin R Espenschied, Duveen Sturgeon, et al.
JAMA Oncology|April 19, 2017
Associations Between Cancer Predisposition Testing Panel Genes and Breast CancerFergus J Couch, Hermela Shimelis, Chunling Hu, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Human Mutation|May 23, 2020
Mutation prevalence tables for hereditary cancer derived from multigene panel testingSteven N Hart, Eric C Polley, Amal Yussuf, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 26, 2014
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patientsHolly LaDuca, A J Stuenkel, Jill S Dolinsky, et al.
Journal of the National Cancer Institute|February 25, 2020
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing CohortChunling Hu, Eric C Polley, Siddhartha Yadav, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 20, 2019
Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohortHongyan Li, Holly LaDuca, Tina Pesaran, et al.
Cancer|April 14, 2019
Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinomaMary Linton B Peters, Lindsey Stobie, Beth Dudley, et al.
Medrxiv : the Preprint Server for Health Sciences|August 23, 2023
A genotype-first approach identifies high incidence of <i>NF1</i> pathogenic variants with distinct disease associationsAnton Safonov, Tomoki T Nomakuchi, Elizabeth Chao, et al.
JCO Precision Oncology|September 10, 2019
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility GenesChunling Hu, Holly LaDuca, Hermela Shimelis, et al.
Human Molecular Genetics|January 25, 2024
Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG/AMP guidelinesCristina Fortuno, Kyriaki Michailidou, Michael Parsons, et al.
JCO Precision Oncology|February 17, 2022
Unexpected <i>CDH1</i> Mutations Identified on Multigene Panels Pose Clinical Management ChallengesKatrina Lowstuter, Carin R Espenschied, Duveen Sturgeon, et al.
JAMA Oncology|April 19, 2017
Associations Between Cancer Predisposition Testing Panel Genes and Breast CancerFergus J Couch, Hermela Shimelis, Chunling Hu, et al.
Pageof 4